The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 56K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shaw, M. K.
Right arrow Articles by Fathman, C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shaw, M. K.
Right arrow Articles by Fathman, C. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1997/5/1711/ $5.00
The Journal of Experimental Medicine, Volume 185, Number 9, May 5, 1997 1711-1714


Brief Definitive Reports

Local Delivery of Interleukin 4 by Retrovirus-Transduced T Lymphocytes Ameliorates Experimental Autoimmune Encephalomyelitis

Michael K. Shaw*, James B. Lorens{ddagger}, Archana Dhawan*, Richard DalCanto*, Harley Y. Tse, Alyssa B. Tran*, Colleen Bonpane*, Shanti L. Eswaran*, Stefan Brocke§, Nora Sarvetnick**, Lawrence Steinman§, Garry P. Nolan§,||, and C. Garrison Fathman*

From the * Department of Medicine, Division of Immunology and Rheumatology, {ddagger} Department of Molecular Pharmacology, Department of Microbiology, and Department of Immunology, § Department of Neurological Sciences, || Department of Immunology, Stanford University School of Medicine, Stanford, California 94305-5111; Department of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, Michigan 48201; and ** Department of Immunology, Scripps Research Institute, La Jolla, California 92034

Experimental autoimmune encephalomyelitis (EAE) is an inflammatory autoimmune disease of the central nervous system which serves as a model for the human disease multiple sclerosis. We demonstrate here that encephalitogenic T cells, transduced with a retroviral gene, construct to express interleukin 4, and can delay the onset and reduce the severity of EAE when adoptively transferred to myelin basic protein–immunized mice. Thus, T lymphocytes transduced with retroviral vectors can deliver "regulatory cytokines" in a site-specific manner and may represent a viable therapeutic strategy for the treatment of autoimmune disease.


Address correspondence to Dr. C. Garrison Fathman, Stanford University School of Medicine, Division of Immunology & Rheumatology, Rm S021, Stanford, CA 94305-5111.

M.K. Shaw is the recipient of a fellowship from the National Multiple Sclerosis Society. J. B. Lorens is the recipient of a fellowship from the Norwegian Cancer Society. This work was supported by National Institutes of Health grants AI36535 and NO1-AR-6-2227.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS